Cosette Pharmaceuticals Announces the Approval and Launch of Metronidazole Gel USP, 1%.
Launch Expands Cosette’s Generic Portfolio Through Organic Development…
Cosette Pharmaceuticals Announces the launch of Griseofulvin Oral Suspension, 125 mg/5 mL.
Launch Enables Access To Patients And Providers, Alleviating Supply Chain…
Cosette Pharmaceuticals Appoints Kevin Hickey, Vice President, Brand Sales and Marketing to Accelerate Transformation
Experienced sales and marketing executive Kevin Hickey will build on and…
Now Available From Cosette Pharmaceuticals: Azor, Benicar, Benicar HCT, Effient, Evoxac, Tribenzor and Welchol
BRIDGEWATER, NJ – OCTOBER 10, 2022: RECENT POSTS…
Now Available CLOMID™ (clomiphene citrate) 50mg Tablets in 10 and 30 count boxes
BRIDGEWATER, NJ – OCTOBER 7, 2022: RECENT POSTS…
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Versions of TAZORAC® (tazarotene) gel, 0.05% and 0.1%, with 180 days Competitive Generic Therapy (CGT) exclusivity
Bridgewater, NJ, United States. September 20, 2022. Cosette Pharmaceuticals,…
Ganesh Pillarisetti has joined Cosette Pharmaceuticals as Vice President, IT
We are pleased to announce Ganesh Pillarisetti has joined the executive team as…
Cosette Pharmaceuticals Appoints Rick Casten as CFO Amid Transformational Growth
Experienced financial executive will build on growth trajectory Bridgewater,…
Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol® Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl
BRIDGEWATER, NJ – JUNE 7, 2022: Cosette Pharmaceuticals, Inc., a New…
Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva® (Docosanol Cream 10%) Including the First Approval in the Pump Format
Bridgewater, NJ and Vadodara, India May 24, 2022/PRNewswire/Cosette…